Evidence map›Paper›PMID 10833508›Full record

ArticleThe Journal of biological chemistry2000

TrkB activation by brain-derived neurotrophic factor inhibits the G protein-gated inward rectifier Kir3 by tyrosine phosphorylation of the channel.

S L Rogalski, S M Appleyard, A Pattillo, G W Terman, C Chavkin

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 69 citations in OpenAlex.

  1. Trial
  2. Article
  3. Neuronal G protein-gated KAmerican journal of physiology. Cell physiology · 2022
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  10. Article
  11. Structural elements in the Girk1 subunit that potentiate G protein-gated potassium channel activity.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  12. Repeated stress dysregulates κ-opioid receptor signaling in the dorsal raphe through a p38α MAPK-dependent mechanism.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
  13. Article
  14. Article
  15. Regulation of wild-type and mutant KCNQ1/KCNE1 channels by tyrosine kinase.Pflugers Archiv : European journal of physiology · 2009
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

S L RogalskiDepartment of Pharmacology and Anesthesiology, University of Washington, Seattle 98195, USA.
S M Appleyard
A Pattillo
G W Terman
C Chavkin
University of Washington · US

Funding

Regulation of Opioid Signaling by Tyr-PhosphorylationR37DA011672 · NIDA · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 2004 to 2013
$2.5M
MODELS OF OPIOID RECEPTOR DESENSITIZATION MECHANISMSR01DA011672 · NIDA · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 1999 to 2003
$902k
NIDA NIH HHS DA11672NIDA NIH HHS R01 DA011672NIDA NIH HHS R37 DA011672
6 · The paper itself

Abstract

G protein-activated inwardly rectifying potassium channels (Kir3) are widely expressed throughout the brain, and regulation of their activity modifies neuronal excitability and synaptic transmission. In this study, we show that the neurotrophin brain-derived neurotrophic factor (BDNF), through activation of TrkB receptors, strongly inhibited the basal activity of Kir3. This inhibition was subunit dependent as functional homomeric channels of either Kir3.1 or Kir3.4 were significantly inhibited, whereas homomeric channels composed of Kir3.2 were insensitive. The general tyrosine kinase inhibitors genistein, Gö 6976, and K252a but not the serine/threonine kinase inhibitor staurosporine blocked the BDNF-induced inhibition of the channel. BDNF was also found to directly stimulate channel phosphorylation because Kir3.1 immunoprecipitated from BDNF-stimulated cells showed enhanced labeling by anti-phosphotyrosine-specific antibodies. The BDNF effect required specific tyrosine residues in the amino terminus of Kir3.1 and Kir3.4 channels. Mutations of either Tyr-12, Tyr-67, or both in Kir3.1 or mutation of either Tyr-32, Tyr-53, or both of Kir3. 4 channels to phenylalanine significantly blocked the BDNF-induced inhibition. The insensitive Kir3.2 was made sensitive to BDNF by adding a tyrosine (D41Y) and a lysine (P32K) upstream to generate a phosphorylation site motif analogous to that present in Kir3.4. These results suggest that neurotrophin activation of TrkB receptors may physiologically control neuronal excitability by direct tyrosine phosphorylation of the Kir3.1 and Kir3.4 subunits of G protein-gated inwardly rectifying potassium channels.

Indexed as

Potassium Channels, Inwardly RectifyingAmino Acid SequenceAnimalsBrain-Derived Neurotrophic FactorCarbazolesDNA, ComplementaryDose-Response Relationship, DrugElectrophysiologyEnzyme ActivationEnzyme InhibitorsGenisteinG Protein-Coupled Inwardly-Rectifying Potassium ChannelsGTP-Binding ProteinsIndole AlkaloidsIndolesLysineBrain-Derived Neurotrophic FactorCarbazolesDNA, ComplementaryEnzyme InhibitorsGenisteinGo 6976G Protein-Coupled Inwardly-Rectifying Potassium ChannelsGTP-Binding ProteinsIndole AlkaloidsIndolesLysinePotassium ChannelsPotassium Channels, Inwardly RectifyingReceptor, trkBRNA, MessengerStaurosporinestaurosporine aglyconeTyrosine

Identifiers

PMID10833508
PMCPMC1276699
OpenAlexW2005899779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.